| 期刊論文| 1. | Nisoli, E.、Tonello, C.、Cardile, A.、Cozzi, V.、Bracale, R.、Tedesco, L.、Carruba, M. O.(2005)。Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS。Science，310(5746)，314-317。   | | 2. | Green, E. D.、Maffei, M.、Braden, V. V.、Proenca, R.、DeSilva, U.、Zhang, Y.、Friedman, J. M.(1995)。The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7。Genome Research，5(1)，5-12。 | | 3. | Ahima, R. S.、Flier, J. S.(2000)。Leptin。Annu Rev Physiol，62，413-437。 | | 4. | Lee, J. H.、Chan, J. L.、Yiannakouris, N.、Kontogianni, M.、Estrada, E.、Seip, R.(2003)。Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects。Journal of Clinical Endocrinology and Metabolism，88，4848-4856。 | | 5. | Friedman, J. M.、Halaas, J. L.(1998)。Leptin and the regulation of body weight in mammals。Nature，395(22)，763-770。 | | 6. | Celleno, L.、Tolaini, M. V.、D'Amore, A.、Perricone, N. V.、Preuss, H. G.(2007)。A dietary supplement containing standardized phaseolus vulgaris extract influences body composition of overweight men and women。International Journal of Medical Sciences，4(1)，45-52。 | | 7. | Steppan, C. M.、Bailey, S. T.、Bhat, S.、Brown, E. J.、Banerjee, R. R.、Wright, C. M.、Patel, H. R.、Ahima, R. S.、Lazar, M. A.(2001)。The hormone resistin links obesity to diabetes。Nature，409，307-312。 | | 8. | Schwartz, M. W.、Woods, S. C.、Porte, D. Jr.、Seeley, R. J.、Baskin, D. G.(2000)。Central nervous system control of food intake。Nature，404，661-671。 | | 9. | Nakazato, M.、Murakami, N.、Date, Y.、Kojima, M.、Matsuo, H.、Kangawa, K.、Matsukura, S.(2001)。A role for ghrelin in the central regulation of feeding。Nature，409，194-198。 | | 10. | Murphy, K. G.、Bloom, S. R.(2006)。Gut hormones and the regulation of energy homeostasis。Nature，444，854-859。 | | 11. | Bianchini, F.、Kaaks, R.、Vainio, H.(2002)。Overweight, obesity, and cancer risk。Lancet Oncol.，3，565-574。 | | 12. | Calle, E. E.、Rodriguez, C.、Walker-Thurmond, K.、Thun, M. J.(2003)。Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults。N. Engl. J. Med.，348，1625-1638。 | | 13. | Calle, E. E.、Kaaks, R.(2004)。Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms。Nat. Rev. Cancer，4，579-591。 | | 14. | Park, E. J.、Lee, J. H.、Yu, G. Y.、He, G.、Ali, Z. R.、Holzer, R. G.(2010)。Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression。Cell，140，197-208。 | | 15. | Rasouli, N.、Kern, P. A.(2008)。Adipocytokines and metabolic compliations of obesity。J. Clin. Endocrinol. Metab.，93，564-573。 | | 16. | Olshansky, S. J.、Passaro, D. J.、Hershow, R. C.、Layden, J.、Carnes, B. A.、Brody, J.、Hayflick, L.、Butler, R. N.、Allison, D. B.、Ludwig, D. S.(2005)。A Potential Decline in Life Expectancy in the United States in the 21st Century。New England Journal of Medicine，352(11)，1138-1145。 | | 17. | Arkinson, T. J.(2008)。Central and peripheral neuroendocrine peptides and signaling in appetite regulation: considerations for obesity pharmacotherapy。Obes. Rev.，9，108-120。 | | 18. | Elmquist, J. K.、Elias, C. F.、Saper, C. B.(1999)。From lesions to leptin: hypothalamic control of food intake and body weight。Neuron，22，221-232。 | | 19. | Ritter, R. C.、Covasa, M.、Matson, C. A.(1999)。Cholecystokinin: Proofs and prospects for involvement in control of food intake and body weight。Neuropeptides，33，387-399。 | | 20. | Näslund, E.、Hellström, P. M.(2007)。Appetite signaling: From gut peptides and enteric nerve to brain。Physiol. Behav.，92，256-262。 | | 21. | Shapiro, A.、Mu, W.、Roncal, C.、Cheng, K. Y.、Johnson, R. J.、Scarpace, P. J.(2008)。Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding。Am. J. Physiol. Regul. Integr. Comp. Physiol.，295，R1370-1375。 | | 22. | Erlanson-Albertsson, C.(2005)。How palatable food disrupts appetite regulation。Basic Clin. Pharmacol. Toxicol.，97，61-73。 | | 23. | Kirkham, T.、Williams, C.(2001)。Synergistic effects of opioid and cannabinoid antagonists on food intake。Psycopharmacologia，153，267-270。 | | 24. | Cota, D.、Proulx, K.、Smiths, K. A. B.、Kozma, S. C.、Thomas, G.、Woods, S. C.(2006)。Hypothalamic mTOR signaling regulates food intake。Science，312，927-930。 | | 25. | Colman, R. J.、Anderson, R. M.、Johnson, S. C.、Kastman, E. K.、Kosmatka, K. J.、Beasley, T. M.(2009)。Caloric restriction delays disease onset and mortality in rhesus monkeys。Science，325，201-204。 | | 26. | Ichimura, A.、Hirasawa, A.、Poulain-Godefroy, O.、Bonnefond, A.、Hara, T.、Yengo, L.(2012)。Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human。Nature，483，350-357。 | | 27. | Margetic, S.、Gazzola, C.、Pegg, G. G.、Hill, R. A.(2002)。Leptin: a review of its peripheral actions and interactions。Int. J. Obes. Relat. Metab. Disord.，26，1407-1433。 | | 28. | Lord, G. M.、Matarese, G.、Howard, J. K.、Baker, R. J.、Bloom, S. R.、Lechler, R. I.(1998)。Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression。Nature，394，897-901。 | | 29. | Taleb, S.、Herbin, O.、Ait-Oufella, H.、Verreth, W.、Gourdy, P.、Barateau, V.(2007)。Defective leptin/ leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis。Arterioscler. Thromb. Vasc. Biol.，27，2691-2698。 | | 30. | Knight, W.、Seth, R.、Boron, J.、Overton, J.(2009)。Short-term physiological hyperleptinemia decreases arterial blood pressure。Regul. Pept.，154，60-68。 | | 31. | Brennan, A. M.、Mantzoros, C. S.(2006)。Drug insight: the role of leptin in human physiology and pathophysiologyemerging clinical applications。Nat. Clin. Pract. Endocrinol. Metab.，2，318-327。 | | 32. | Fantuzzi, G.、Faggioni, R.(2000)。Leptin in the regulation of immunity, inflammation, and hematopoiesis。J. Leukoc. Biol.，68，437-446。 | | 33. | Milan, G.、Granzotto, M.、Scarda, A.、Calcagno, A.、Pagano, C.、Federspil, G.(2001)。Resistin and adiponectin expression in visceral fat of obese rate: effect of weight loss。Obes. Res.，10，1095-1103。 | | 34. | Silswal, N.、Singh, A. K.、Aruna, B.、Mukhopadhyay, S.、Ghosh, S.、Ehtesham, N. Z.(2005)。Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-kappa B-dependent pathway。Biochem. Biophys. Res. Commun.，334，1092-1101。 | | 35. | Verma, S.、Li, S. H.、Wang, C. H.、Fedak, P. W.、Li, R. K.、Weisel, R. D.(2003)。Resistin promotes endothelial cell activation: further evidence of adipokineendothelial interaction。Circulation，108，736-740。 | | 36. | McTernan, C. L.、McTernan, P. G.、Harte, A. L.、Levick, P. L.、Barnett, A. H.、Kumar, S.(2002)。Resistin, central obesity, and type 2 diabetes。Lancet，359，46-47。 | | 37. | Duman, B. S.、Turkoglu, C.、Gunay, D.、Cagatay, P.、Demiroglu, C.、Buyukdevrim, A. S.(2003)。The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity。Diabetes Nutr. Meta.，16，243-250。 | | 38. | Way, J. M.、Görgün, C. Z.、Tong, Q.、Uysal, K. T.、Brown, K. K.、Harringtow, W. W.(2001)。Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator activated receptor gamma agonists。J. Biol. Chem.，276，25651-25653。 | | 39. | Dawson, D. W.、Volpert, O. V.、Gillis, P.、Crawford, S. E.、Xu, H.、Benedict, W.、Bouck, N. P.(1999)。Pigment epitheliumderived factor: a potent inhibitor of angiogenesis。Science，285，245-248。 | | 40. | Gao, G.、Li, Y.、Gee, S.、Dudley, A.、Fant, J.、Crosson, C.(2002)。Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor: a possible mechanism for the antiangiogenic activity of plasminogen kringle 5。J. Biol. Chem.，277，9492-9497。 | | 41. | Guan, M.、Pang, C. P.、Yam, H. F.、Cheung, K. F.、Liu, W. W.、Lu, Y.(2004)。Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor。Cancer Gene Ther.，11，325-332。 | | 42. | Ho, T. C.、Chen, S. L.、Yang, Y. C.、Liao, C. L.、Cheng, H. C.、Tsao, Y. P.(2007)。PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells。Cardiovasc. Res.，76，213-223。 | | 43. | Tombran-Tink, J.、Chader, G. G.、Johnson, L. V.(1991)。PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity。Exp. Eye Res.，53，411-414。 | | 44. | Shapiro, L.、Scherer, P. E.(1998)。The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor。Curr. Biol.，8，335-338。 | | 45. | Ukkola, O.、Santaniemi, M.(2002)。Adiponectin: a link between excess adiposity and associated?。J. Mol. Med.，80，696-702。 | | 46. | Coppola, A.、Marfella, R.、Coppola, L.、Tagliamonte, E.、Fontana, D.、Liguori, E.(2008)。Effect of weight loss on coronary circulation and adiponectin levels in obese women。Int. J. Cardiol.，134，414-416。 | | 47. | Kaklamani, V. G.、Sadim, M.、His, A.、Offit, K.、Oddoux, C.、Ostrer, H.(2008)。Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk。Cancer Res.，68，3178-3184。 | | 48. | Renaldi, O.、Pramono, B.、Sinorita, H.、Purnomo, L. B.、Asdie, R. H.、Asdie, A. H.(2009)。Hypoadiponectinemia: a risk factor for metabolic syndrome。Acta. Med. Indones.，41，20-24。 | | 49. | Yamauchi, T.、Kamon, J.、Ito, Y.、Tsuchida, A.、Yokomizo, T.、Kita, S.(2003)。Cloning of adiponectin receptors that mediate antidiabetic metabolic effects。Nature，423，762-769。 | | 50. | Oh, D. K.、Ciaraldi, T.、Henry, R. R.(2007)。Adiponectin in health and disease。Diabetes Obes. Metab.，9，282-289。 | | 51. | Zhu, N.、Pankow, J. S.、Ballantyne, C. M.、Couper, D.、Hoogeveen, R. C.、Pereira, M.(2010)。High-molecularweight adiponectin and the risk of type 2 diabetes in the ARIC study。J. Clin. Endocrinol. Metab.，95，5097-5104。 | | 52. | Díez, J. J.、Iglesias, P.(2003)。The role of the novel adipocytederived hormone adiponectin in human disease。Eur. J. Endocrinol.，148，293-300。 | | 53. | Lara-Castro, C.、Fu, Y.、Chung, B. H.、Garvey, W. T.(2007)。Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease。Curr. Opin. Lipidol.，18，263-270。 | | 54. | Hug, C.、Wang, J.、Ahmad, N. S.、Bogan, J. S.、Tsao, T. S.、Lodish, H. F.(2004)。T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin。Proc. Natl. Acad. Sci. USA，101，10308-10313。 | | 55. | Boncela, J.、Papiewska, I.、Fijalkowska, I.、Walkowiak, B.、Cierniewski, C. S.(2001)。Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity。J. Biol. Chem.，276，35305-35311。 | | 56. | Elokdah, H.、Abou-Gharbia, M.、Hennan, J. K.、McFariane, G.、Mugford, C. P.、Krishnamurthy, G.(2004)。Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization。J. Med. Chem.，47，3491-3494。 | | 57. | Haviv, F.、Bradley, M. F.、Kalvin, D. M.、Schneider, A. J.、Davidson, D. J.、Majest, S. M.(2005)。Thrombospoudin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities。J. Med. Chem.，48，2836-2846。 | | 58. | Samal, B.、Sun, Y.、Stearns, G.、Xie, C.、Suggs, S.、McNiece, I.(1994)。Cloning and characterization of the cDNA encoding a novel human pre-B-cell colonyenhancing factor。Mol. Cell. Biol.，14，1431-1437。 | | 59. | Fukuhara, A.、Matsuda, M.、Nishizawa, M.、Segawa, K.、Tanaka, M.、Kishimoto, K.(2005)。Visfatin: a protein secreted by visceral fat that mimic the effects of insulin。Science，307，426-430。 | | 60. | Martinon, F.、Burns, K.、Tschopp, J.(2002)。The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta。Mol. Cell，10，417-426。 | | 61. | Yu, H. B.、Finlay, B. B.(2008)。The caspase-1 inflammasome: a pilot of innate immune responses。Cell Host. Microbe，4，198-208。 | | 62. | Guarda, G.、Dostert, C.、Staehli, F.、Cabalzar, K.、Castillo, R.、Tardivel, A.(2009)。T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes。Nature，460，269-274。 | | 63. | Yang, Q.、Graham, T. E.、Mody, N.、Preitner, F.、Peroni, O. D.、Zabolotny, J. M.(2005)。Serum retinal protein 4 contributes to insulin resistance in obesity and type 2 diabetes。Nature，436，356-362。 | | 64. | Herman, M. A.、Kahn, B. B.(2006)。Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony。J. Clin. Invest.，116，1767-1775。 | | 65. | Yong, E. D.(2012)。Gut microbes establish your identity。Discover，1/2，41。 | | 66. | DeSouza, C.、Fonseca, V.(2009)。Therapeutic targets to reduce cardiovascular disease in type 2 diabetes。Nat. Rev. Drug Discov.，8，361-367。 | | 67. | Neyrinck, A. M.、Delzenne, N. M.(2010)。Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders。Curr. Opin. Clin. Nutr. Meta. Care，13，722-728。 | | 68. | Yuliana, N. D.、Jahangir, M.、Korthout, H.、Choi, Y. H.、Kim, H. K.、Verpoorte, R.(2010)。Obesity management: Comprephensive review on herbal medicine for energy intake suppression。Obes. Rev.，12，499-514。 | | 69. | Delzenne, N. M.、Neyrinck, A. M.、Bäckhed, F.、Cani, P. D.(2011)。Targeting gut microbiota in obesity: effects of prebiotics and probiotics。Nature Reviews Endocrinology，7(11)，639-646。 | | 70. | Lin, S. J.、Defossez, P. A.、Guarente, L.(2000)。Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae。Science，2589，2126-2128。 | | 71. | Frye, R. A.(2000)。Phylogenetic classification of prokaryotic and eukaryotic Sir 2-like proteins。Biochem. Biophys. Res. Commun.，273，793-798。 | | 72. | Lavu, S.、Boss, O.、Elliott, P. J.、Lambert, P. D.(2008)。Sirtuinsnovel therapeutic targets to treat age-associated diseases。Nat. Rev. Drug Discov.，7，841-853。 | | 73. | Singh, K. K.(2004)。Mitochondrial dysfunction is a common phenotype in aging and cancer。Ann. NY Acad. Sci.，1019，260-264。 | | 74. | Nemoto, S. M.、Fergusson, M.、Finkel, T.(2005)。SIRT1 functionally interacts with the metabolic regulator and transcriptional coativator PGC-1α。J. Biol. Chem.，280，16456-16460。 | | 75. | Marambaud, P.、Zhao, H.、Davies, P.(2005)。Reseveratrol promotes clearance of Alzheimer's disease amyloid-β peptides。J. Biol. Chem.，280，37377-37382。 | | 76. | Dasgupta, B.、Milbrandt, J.(2007)。Resveratrol stimulates AMP kinase activity in neurons。Proc. Natl. Acad. Sci. USA，104，7217-7222。 | | 77. | Jones, D.(2009)。Novel pharmacotherapies for obesity poised to enter market。Nat. Rev.，8，833-834。 | | 78. | Chen, C. F.、Chiou, W. F.、Zhang, J. T.(2008)。Comparison of pharmacological effects of Panax ginseng and Panax quinquefolium。Acta. Pharmacol. Sin.，29，1103-1108。 | | 79. | Liao, J. F.、Shen, Y. C.、Huang, Y. T.、Chen, C. F.(2012)。Pharmacology of polysaccharides from Ginseng species。Int. J. Biomed. Pharmaceut. Sci.，6，63-69。 | | 80. | Kim, J. H.、Hahm, D. H.、Yang, D. C.、Kim, J. H.、Lee, H. J.、Shim, I.(2005)。Effect of crude saponin of Korean red ginseng on high-fat diet induced obesity in the rat。J. Pharmacol. Sci.，97，124-131。 | | 81. | Kim, J. H.、Kang, S. A.、Han, S. M.、Shim, I.(2008)。Comparison of the antiobesity effects of the protopanaxadioland protopanaxatrioltype saponins of red ginseng。Phytother. Res.，23，78-85。 | | 82. | Fordyce-Baum, M.、Langer, L.、Mantero-Atienza, E.、Crass, R.、Beach, R.(1989)。Use of an expanded-wholewheat product in the reduction of body weight and serum lipids in obese females。Am. J. Clin. Nutr.，50，30-36。 | | 83. | Ekanem, A. P.、Wang, M.、Simon, J. E.、Moreno, D. A.(2007)。Antiobesity properties of two African plants (Afromomum meleguetta and Spilanthes acmella) by pancreatic lipase inhibition。Phytother. Res.，21，1253-1255。 | | 84. | Won, S. R.、Kim, S. K.、Kim, Y. M.、Lee, P. H.、Ryu, J. H.、Kim, J. W.、Rhee, H. I.(2007)。Licochalcone A: a lipase inhibitor from the roots of Glycyrrhiza uralensis。Food Res. Int.，40，1046-1050。 | | 85. | Lei, F.、Zhang, X. N.、Wang, W.、Xing, D. M.、Xie, W. D.、Su, H.、Du, L. J.(2007)。Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice。Int. J. Obes.，31，1023-1029。 | | 86. | Han, L. K.、Sumiyoshi, M.、Zhang, J.、Liu, M. X.、Zhang, X. F.、Zheng, Y. N.、Okuda, H.、Kimura, Y.(2003)。Anti-obesity action of Salix matsudana leaves (Part 1). Antiobesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals。Phytother. Res.，17，1188-1194。 | | 87. | Han, L. K.、Sumiyoshi, M.、Zheng, Y. N.、Okuda, H.、Kimura, Y.(2003)。Antiobesity action of Salix matsudana leaves (Part 2). Isolation of anti-obesity effectors from polyphenol fractions of Salix matsudana。Phytother. Res.，17，1195-1198。 | | 88. | Ono, Y.、Hattori, E.、Fukaya, Y.、Imai, S.、Ohizumi, Y.(2006)。Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats。J. Ethnopharmacol.，106，238-244。 | | 89. | Oku, T.、Yamada, M.、Nakamura, M.、Sadamori, N.、Nakamura, S.(2007)。Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity。Br. J. Nutr.，95，933-938。 | | 90. | Westerterp-Plantenga, M. S.、Smeets, A.、Lejeune, M. P. G.(2004)。Sensory and gastrointestinal satiety effects of capsaicin on food intake。Int. J. Obes. Relat. Metab. Disord.，29，682-688。 | | 91. | Smeets, A.、Westerterp-Plantenga, M.(2009)。The acute effects of a lunch containing capsaicin on energy and substrate utilisation, hormones, and satiety。Eur J. Nutr.，48，229-234。 | | 92. | Gonzalez, C.、Fernandez, M.、Sahagun, A.、Garcia, V.、Diez, L.、Calle, P.、Castro, R.、Sierra, V.(2004)。Glucomannan: properties and therapeutic applications。Nutr. Hosp.，19，45-50。 | | 93. | Rumalla, C.、Avula, B.、Shukla, Y.、Wang, Y.、Pawar, R.、Smillie, T.、Khan, I.(2008)。Chemical fingerprint of Hoodia species, dietary supplements, and related genera by using HPTLC。J. Sep. Sci.，31，3959-3964。 | | 94. | MacLean, D. B.、Luo, L. G.(2004)。Increased ATP content/ production in the hypothalamus may be a signal for energy-sensing of satiety: studies of the anorectic mechanism of a plant steroidal glycoside。Brain Res.，1020，1-11。 | | 95. | Kumar, A.、Vimalavathini, R.(2004)。Possible anorectic effect of methanol extract of Benincasa hispida (Thunb)。Cogn, fruit. Indian J. Pharmacol.，36，348-350。 | | 96. | Kumarnsit, E.、Keawpradub, N.、Nuankaew, W.(2006)。Acute and long-term effects of alkaloid extract of Mitragyna speciosa on food and water intake and body weight in rats。Fitoterapia，77，339-345。 | | 97. | Kalix, P.(1996)。Catha edulis, a plant that has amphetamine effects。Pharm. World Sci.，18，69-73。 | | 98. | Murray, C. D. R.、Le Roux, C. W.、Emmanuel, A. V.、Halket, J. M.、Przyborowska, A. M.、Kamm, M. A.、Murray-Lyon, I. M.(2008)。The effect of Khat (Catha edulis) as an appetite suppressant is independent of ghrelin and PYY secretion。Appetite，51，747-750。 | | 99. | Lewis, Y. S.、Neelakantan, S.(1965)。(-)-Hydroxycitric acidthe principal acid in the fruits of Garcinia cambogia desr。Phytochemistry，4，619-625。 | | 100. | Hansawasdi, C.、Kawabata, J.、Kasai, T.(2000)。α-Amylase inhibitors from roselle (Hibiscus sabdariffa Linn.) tea。Biosci. Biotechnol. Biochem.，64，1041-1043。 | | 101. | Krotkiewski, M.(1984)。Effect of guar gum on bodyweight, hunger ratings and metabolism in obese subjects。Br. J. Nutr.，52，97-105。 | | 102. | Darwiche, G.、Bjorgell, O.、Almer, L. O.(2003)。The addition of locustbean gum but not water delayed the gastric emptying rate of a nutrient semisolid meal in healthy subjects。BMC Gastroenterol.，3，12。 | | 103. | Kuriyan, R.、Raj, T.、Srinivas, S.、Vaz, M.、Rajendran, R.、Kurpad, A.(2007)。Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women。Appetite，48，338-344。 | | 104. | Hou, W.、Li, Y.、Zhang, Q.、Wei, X.、Peng, A.、Chen, L.、Wei, Y.(2008)。Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha-glucosidase inhibitors。Phytother. Res.，23，614-618。 | | 105. | Hara, K.、Yamauchi, T.、Kadowaki, T.(2005)。Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans。Curr. Diab. Rep.，5，136-140。 | 圖書| 1. | Kiangsu Institute of Modern Medicine(1977)。Encyclopedia of Chinese drugs。Shanghai：Shanghai Scientific and Technical Publications。 | 其他| 1. | (20081023)。Anti-obesity drug use suspended。 | 圖書論文| 1. | Powers, A. C.、D'Alessio, D.(2011)。Endocrine pancreas and pharmacotherapy of diabetes millitus。Goodman & Gilman's The pharmacological basis of therapeutics。New York：McGraw-Hill Co., Inc.。 | | 2. | Standaert, D. G.、Roberson, E. D.(2011)。Treatment of central nervous system degenerative disorders。Goodman & Gilman's the pharmacological basis of therapeutics。New York：McGraw-Hill Co., Inc.。 | | 3. | Sharkey, K. A.、Wallace, J. L.(2011)。Treatment of disorders of bowel motility and water flux; Anti-emetics; Agents used in biliary and parcreatic disease。Goodman & Gilman's the pharmacological basis of therapeutics。New York：McGraw-Hill Co., Inc.。 | |